{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T08:13:29Z","timestamp":1776845609381,"version":"3.51.2"},"reference-count":81,"publisher":"National Institute for Health and Care Research","issue":"60","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["06\/402\/94"],"award-info":[{"award-number":["06\/402\/94"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"<jats:sec id=\"abs1-1\"><jats:title>Background<\/jats:title><jats:p>Uncertainty about optimal red blood cell transfusion thresholds in cardiac surgery is reflected in widely varying transfusion rates between surgeons and cardiac centres.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-2\"><jats:title>Objective<\/jats:title><jats:p>To test the hypothesis that a restrictive compared with a liberal threshold for red blood cell transfusion after cardiac surgery reduces post-operative morbidity and health-care costs.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-3\"><jats:title>Design<\/jats:title><jats:p>Multicentre, parallel randomised controlled trial and within-trial cost\u2013utility analysis from a UK NHS and Personal Social Services perspective. We could not blind health-care staff but tried to blind participants. Random allocations were generated by computer and minimised by centre and operation.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-4\"><jats:title>Setting<\/jats:title><jats:p>Seventeen specialist cardiac surgery centres in UK NHS hospitals.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-5\"><jats:title>Participants<\/jats:title><jats:p>Patients aged &gt;\u200916 years undergoing non-emergency cardiac surgery with post-operative haemoglobin &lt;\u20099\u2009g\/dl. Exclusion criteria were: unwilling to have transfusion owing to beliefs; platelet, red blood cell or clotting disorder; ongoing or recurrent sepsis; and critical limb ischaemia.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-6\"><jats:title>Interventions<\/jats:title><jats:p>Participants in the liberal group were eligible for transfusion immediately after randomisation (post-operative haemoglobin &lt;\u20099\u2009g\/dl); participants in the restrictive group were eligible for transfusion if their post-operative haemoglobin fell to &lt;\u20097.5\u2009g\/dl during the index hospital stay.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-7\"><jats:title>Main outcome measures<\/jats:title><jats:p>The primary outcome was a composite outcome of any serious infectious (sepsis or wound infection) or ischaemic event (permanent stroke, myocardial infarction, gut infarction or acute kidney injury) during the 3 months after randomisation. Events were verified or adjudicated by blinded personnel. Secondary outcomes included blood products transfused; infectious events; ischaemic events; quality of life (European Quality of Life-5 Dimensions); duration of intensive care or high-dependency unit stay; duration of hospital stay; significant pulmonary morbidity; all-cause mortality; resource use, costs and cost-effectiveness.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-8\"><jats:title>Results<\/jats:title><jats:p>We randomised 2007 participants between 15 July 2009 and 18 February 2013; four withdrew, leaving 1000 and 1003 in the restrictive and liberal groups, respectively. Transfusion rates after randomisation were 53.4% (534\/1000) and 92.2% (925\/1003). The primary outcome occurred in 35.1% (331\/944) and 33.0% (317\/962) of participants in the restrictive and liberal groups [odds ratio (OR) 1.11, 95% confidence interval (CI) 0.91 to 1.34;<jats:italic>p<\/jats:italic>\u2009=\u20090.30], respectively. There were no subgroup effects for the primary outcome, although some sensitivity analyses substantially altered the estimated OR. There were no differences for secondary clinical outcomes except for mortality, with more deaths in the restrictive group (4.2%, 42\/1000 vs. 2.6%, 26\/1003; hazard ratio 1.64, 95% CI 1.00 to 2.67;<jats:italic>p<\/jats:italic>\u2009=\u20090.045). Serious post-operative complications excluding primary outcome events occurred in 35.7% (354\/991) and 34.2% (339\/991) of participants in the restrictive and liberal groups, respectively. The total cost per participant from surgery to 3 months postoperatively differed little by group, just \u00a3182 less (standard error \u00a3488) in the restrictive group, largely owing to the difference in red blood cells cost. In the base-case cost-effectiveness results, the point estimate suggested that the restrictive threshold was cost-effective; however, this result was very uncertain partly owing to the negligible difference in quality-adjusted life-years gained.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-9\"><jats:title>Conclusions<\/jats:title><jats:p>A restrictive transfusion threshold is not superior to a liberal threshold after cardiac surgery. This finding supports restrictive transfusion due to reduced consumption and costs of red blood cells. However, secondary findings create uncertainty about recommending restrictive transfusion and prompt a new hypothesis that liberal transfusion may be superior after cardiac surgery. Reanalyses of existing trial datasets, excluding all participants who did not breach the liberal threshold, followed by a meta-analysis of the reanalysed results are the most obvious research steps to address the new hypothesis about the possible harm of red blood cell transfusion.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-10\"><jats:title>Trial registration<\/jats:title><jats:p>Current Controlled Trials ISRCTN70923932.<\/jats:p><\/jats:sec><jats:sec id=\"abs1-11\"><jats:title>Funding<\/jats:title><jats:p>This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in<jats:italic>Health Technology Assessment<\/jats:italic>; Vol. 20, No. 60. See the NIHR Journals Library website for further project information.<\/jats:p><\/jats:sec>","DOI":"10.3310\/hta20600","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T06:59:47Z","timestamp":1471330787000},"page":"1-260","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["A multicentre randomised controlled trial of Transfusion Indication Threshold Reduction on transfusion rates, morbidity and health-care resource use following cardiac surgery (TITRe2)"],"prefix":"10.3310","volume":"20","clinical-trial-number":[{"clinical-trial-number":"isrctn70923932","registry":"10.18810\/isrctn","type":"results"}],"author":[{"given":"Barnaby C","family":"Reeves","sequence":"first","affiliation":[{"name":"Clinical Trials and Evaluation Unit, School of Clinical Sciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Pike","sequence":"additional","affiliation":[{"name":"Clinical Trials and Evaluation Unit, School of Clinical Sciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris A","family":"Rogers","sequence":"additional","affiliation":[{"name":"Clinical Trials and Evaluation Unit, School of Clinical Sciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel CM","family":"Brierley","sequence":"additional","affiliation":[{"name":"Clinical Trials and Evaluation Unit, School of Clinical Sciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A","family":"Stokes","sequence":"additional","affiliation":[{"name":"Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Wordsworth","sequence":"additional","affiliation":[{"name":"Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel L","family":"Nash","sequence":"additional","affiliation":[{"name":"Clinical Trials and Evaluation Unit, School of Clinical Sciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Miles","sequence":"additional","affiliation":[{"name":"Clinical Trials and Evaluation Unit, School of Clinical Sciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D","family":"Mumford","sequence":"additional","affiliation":[{"name":"School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Cohen","sequence":"additional","affiliation":[{"name":"Division of Specialised Services, University Hospitals Bristol NHS Foundation Trust, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianni D","family":"Angelini","sequence":"additional","affiliation":[{"name":"Bristol Heart Institute, School of Clinical Sciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin J","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences and National Institute for Health Research Leicester Biomedical Research Unit in Cardiovascular Medicine, University of Leicester, Leicester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the TITRe2 investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6221","published-online":{"date-parts":[[2016,8]]},"reference":[{"key":"key20160811141512375_ref1-bib1","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/01.CCM.0000171531.06133.B0","article-title":"Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: implications on operative outcome","volume":"33","author":"Habib","year":"2005","journal-title":"Crit Care Med"},{"key":"key20160811141512375_ref1-bib2","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1161\/CIRCULATIONAHA.107.698977","article-title":"Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery","volume":"116","author":"Murphy","year":"2007","journal-title":"Circulation"},{"key":"key20160811141512375_ref1-bib3","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1161\/CIRCULATIONAHA.107.718353","article-title":"Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study","volume":"117","author":"Karkouti","year":"2008","journal-title":"Circulation"},{"key":"key20160811141512375_ref1-bib4","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1001\/jama.2010.1406","article-title":"Variation in use of blood transfusion in coronary artery bypass graft surgery","volume":"304","author":"Bennett-Guerrero","year":"2010","journal-title":"JAMA"},{"key":"key20160811141512375_ref1-bib5","volume-title":"National Comparative Audit of Blood Transfusion: 2011 Audit of Blood Transfusion in Adult Cardiac Surgery","author":"Murphy","year":"2013"},{"key":"key20160811141512375_ref1-bib6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-3148.2009.00933.x","article-title":"The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood Service","volume":"19","author":"Wells","year":"2009","journal-title":"Transfus Med"},{"key":"key20160811141512375_ref1-bib7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.transci.2014.02.020","article-title":"A multi-centre randomised controlled trial of Transfusion Indication Threshold Reduction on transfusion rates, morbidity and healthcare resource use following cardiac surgery: study protocol","volume":"50","author":"Brierley","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"key20160811141512375_ref1-bib8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1378\/chest.108.3.767","article-title":"RBC transfusion in the ICU. Is there a reason?","volume":"108","author":"Corwin","year":"1995","journal-title":"Chest"},{"key":"key20160811141512375_ref1-bib9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/00000542-199802000-00009","article-title":"Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group","volume":"88","author":"Stover","year":"1998","journal-title":"Anesthesiology"},{"key":"key20160811141512375_ref1-bib10","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1097\/01.CCM.0000217920.48559.D8","article-title":"Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting","volume":"34","author":"Koch","year":"2006","journal-title":"Crit Care Med"},{"key":"key20160811141512375_ref1-bib11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/ALN.0b013e318229a7e8","article-title":"Influence of erythrocyte transfusion on the risk of acute kidney injury after cardiac surgery differs in anemic and nonanemic patients","volume":"115","author":"Karkouti","year":"2011","journal-title":"Anesthesiology"},{"key":"key20160811141512375_ref1-bib12","doi-asserted-by":"publisher","first-page":"CD002042","DOI":"10.1002\/14651858.cd002042.pub3","article-title":"Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion","volume":"4","author":"Carson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key20160811141512375_ref1-bib13","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1056\/NEJMoa1012452","article-title":"Liberal or restrictive transfusion in high-risk patients after hip surgery","volume":"365","author":"Carson","year":"2011","journal-title":"N Engl J Med"},{"key":"key20160811141512375_ref1-bib14","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.ahj.2013.03.001","article-title":"Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease","volume":"165","author":"Carson","year":"2013","journal-title":"Am Heart J"},{"key":"key20160811141512375_ref1-bib15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1001\/jama.2012.50429","article-title":"Outcomes using lower vs higher hemoglobin thresholds for red blood cell transfusion","volume":"309","author":"Carson","year":"2013","journal-title":"JAMA"},{"key":"key20160811141512375_ref1-bib16","volume-title":"The 2012 Annual SHOT Report","author":"Bolton-Maggs","year":"2013"},{"key":"key20160811141512375_ref1-bib17","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1537-2995.2010.02882.x","article-title":"Implications of demographics on future blood supply: a population-based cross-sectional study","volume":"51","author":"Greinacher","year":"2011","journal-title":"Transfusion"},{"key":"key20160811141512375_ref1-bib18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1537-2995.2009.02518.x","article-title":"Activity-based costs of blood transfusions in surgical patients at four hospitals","volume":"50","author":"Shander","year":"2010","journal-title":"Transfusion"},{"key":"key20160811141512375_ref1-bib19","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.athoracsur.2010.11.078","article-title":"2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthetists blood conservation clinical practice guidelines","volume":"91","author":"Ferraris","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"key20160811141512375_ref1-bib20","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1097\/CCM.0b013e3181b39f1b","article-title":"Clinical practice guideline: red blood cell transfusion in adult trauma and critical care","volume":"37","author":"Napolitano","year":"2009","journal-title":"Crit Care Med"},{"key":"key20160811141512375_ref1-bib21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.7326\/0003-4819-157-1-201206190-00429","article-title":"Red blood cell transfusion: a clinical practice guideline from the AABB*","volume":"157","author":"Carson","year":"2012","journal-title":"Ann Intern Med"},{"key":"key20160811141512375_ref1-bib22","volume-title":"Global Forum for Blood Safety: Patient Blood Management. Priorities for Action","author":"World Health Organization (WHO)","year":"2011"},{"key":"key20160811141512375_ref1-bib23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bpa.2012.12.007","article-title":"Drivers for change: Western Australia Patient Blood Management Program (WA PBMP), World Health Assembly (WHA) and Advisory Committee on Blood Safety and Availability (ACBSA)","volume":"27","author":"Farmer","year":"2013","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"key20160811141512375_ref1-bib24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0022-5223(19)34782-8","article-title":"Comparison of two transfusion strategies after elective operations for myocardial revascularization","volume":"104","author":"Johnson","year":"1992","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key20160811141512375_ref1-bib25","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1046\/j.1537-2995.1999.39101070.x","article-title":"Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome","volume":"39","author":"Bracey","year":"1999","journal-title":"Transfusion"},{"key":"key20160811141512375_ref1-bib26","first-page":"41","article-title":"A pilot randomized controlled trial of the effect of transfusion- threshold reduction on transfusion rates and morbidity after cardiac surgery","volume":"9","author":"Murphy","year":"2007","journal-title":"Transfus Altern Transfus Med"},{"key":"key20160811141512375_ref1-bib27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0140-6736(86)90838-X","article-title":"A scoring method (ASEPSIS) for postoperative wound infections for use in clinical trials of antibiotic prophylaxis","volume":"1","author":"Wilson","year":"1986","journal-title":"Lancet"},{"key":"key20160811141512375_ref1-bib28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0195-6701(90)90002-6","article-title":"The use of the wound scoring method \u2018ASEPSIS\u2019 in postoperative wound surveillance","volume":"16","author":"Wilson","year":"1990","journal-title":"J Hosp Infect"},{"issue":"30","key":"key20160811141512375_ref1-bib29","doi-asserted-by":"publisher","DOI":"10.3310\/hta15300","article-title":"Identification of risk factors by systematic review and development of risk-adjusted models for surgical site infection","volume":"15","author":"Gibbons","year":"2011","journal-title":"Health Technol Assess"},{"key":"key20160811141512375_ref1-bib30","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"key20160811141512375_ref1-bib31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol \u2013 a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy"},{"key":"key20160811141512375_ref1-bib32","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988","edition":"2nd edn."},{"key":"key20160811141512375_ref1-bib33","doi-asserted-by":"publisher","first-page":"A131","DOI":"10.1186\/1745-6215-12-S1-A131","article-title":"Adherence in a randomised controlled trial comparing liberal and restrictive red blood cell (RBC) transfusion protocols after cardiac surgery (TITRe2)","volume":"12","author":"Pike","year":"2011","journal-title":"Trials"},{"key":"key20160811141512375_ref1-bib34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13063-015-0564-x","article-title":"Transfusion Indication Threshold Reduction (TITRe2) randomised controlled trial in cardiac surgery: statistical analysis plan","volume":"16","author":"Pike","year":"2015","journal-title":"Trials"},{"key":"key20160811141512375_ref1-bib35","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1191\/0962280202sm291ra","article-title":"Analysis of repeated measures data with clumping at zero","volume":"11","author":"Tooze","year":"2002","journal-title":"Stat Methods Med Res"},{"key":"key20160811141512375_ref1-bib36","doi-asserted-by":"publisher","first-page":"R16","DOI":"10.1186\/cc9960","article-title":"Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery","volume":"15","author":"Englberger","year":"2011","journal-title":"Crit Care"},{"key":"key20160811141512375_ref1-bib37","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1001\/jama.2010.1446","article-title":"Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial","volume":"304","author":"Hajjar","year":"2010","journal-title":"JAMA"},{"key":"key20160811141512375_ref1-bib38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1537-2995.2011.03236.x","article-title":"A randomized controlled pilot study of adherence to transfusion strategies in cardiac surgery","volume":"52","author":"Shehata","year":"2012","journal-title":"Transfusion"},{"key":"key20160811141512375_ref1-bib39","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00198-2","article-title":"Indications for red cell transfusion in cardiac surgery: a systematic review and meta-analysis of randomized controlled trials and observational studies","author":"Patel","year":"2015","journal-title":"Lancet Haematol"},{"key":"key20160811141512375_ref1-bib40","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S0140-6736(05)66461-6","article-title":"Multiplicity in randomised trials I: endpoints and treatments","volume":"365","author":"Schulz","year":"2005","journal-title":"Lancet"},{"key":"key20160811141512375_ref1-bib41","volume-title":"Social Value Judgements: Principles for the Development of NICE Guidance","author":"NICE","year":"2008","edition":"2nd edn."},{"key":"key20160811141512375_ref1-bib42","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/bmj.313.7052.275","article-title":"Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party","volume":"313","author":"Drummond","year":"1996","journal-title":"BMJ"},{"key":"key20160811141512375_ref1-bib43","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2005","edition":"3rd edn."},{"key":"key20160811141512375_ref1-bib44","volume-title":"Guide to the Methods of Technology Appraisal 2013","author":"NICE","year":"2013"},{"key":"key20160811141512375_ref1-bib45","volume-title":"National Schedule of Reference Costs 2012\u201313","author":"Department of Health","year":"2013"},{"key":"key20160811141512375_ref1-bib46","volume-title":"NHS Blood and Transplant Price List 2012\u20132013","author":"NHS Blood and Transplant","year":"2012"},{"key":"key20160811141512375_ref1-bib47","article-title":"Electronic Marketing Information Tool (eMIT)","volume-title":"Drugs and Pharmaceutical Electronic Market Information (eMit)","author":"Department of Health Commercial Medicines Unit"},{"key":"key20160811141512375_ref1-bib48","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2013","edition":"66 edn."},{"key":"key20160811141512375_ref1-bib49","volume-title":"Unit Costs of Health and Social Care 2013","author":"Curtis","year":"2013"},{"key":"key20160811141512375_ref1-bib50","volume-title":"A Social Tariff for Euroqol: Results from a UK General Population Survey","author":"Dolan","year":"1995"},{"key":"key20160811141512375_ref1-bib51","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"key20160811141512375_ref1-bib52","doi-asserted-by":"crossref","DOI":"10.1002\/9780470316696","volume-title":"Multiple Imputation For Non-Response In Surveys","author":"Rubin","year":"1987"},{"key":"key20160811141512375_ref1-bib53","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/hec.944","article-title":"Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility","volume":"14","author":"Manca","year":"2005","journal-title":"Health Econ"},{"key":"key20160811141512375_ref1-bib54","doi-asserted-by":"publisher","first-page":"e005094","DOI":"10.1136\/bmjopen-2014-005094","article-title":"Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial","volume":"4","author":"Dakin","year":"2014","journal-title":"BMJ Open"},{"key":"key20160811141512375_ref1-bib55","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa1403612","article-title":"Liberal or restrictive transfusion after cardiac surgery","volume":"372","author":"Murphy","year":"2015","journal-title":"N Engl J Med"},{"issue":"44","key":"key20160811141512375_ref1-bib56","doi-asserted-by":"publisher","DOI":"10.3310\/hta10440","article-title":"Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model","volume":"10","author":"Davies","year":"2006","journal-title":"Health Technol Assess"},{"key":"key20160811141512375_ref1-bib57","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2009","edition":"58 edn."},{"key":"key20160811141512375_ref1-bib58","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/hec.766","article-title":"Missing .\u2009.\u2009. presumed at random: cost-analysis of incomplete data","volume":"12","author":"Briggs","year":"2003","journal-title":"Health Econ"},{"key":"key20160811141512375_ref1-bib59","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/oxfordjournals.ije.a019909","article-title":"An introduction to instrumental variables for epidemiologists","volume":"29","author":"Greenland","year":"2000","journal-title":"Int J Epidemiol"},{"key":"key20160811141512375_ref1-bib60","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1365-3148.2008.00870.x","article-title":"Fresh blood for everyone? Balancing availability and quality of stored RBCs","volume":"18","author":"Dzik","year":"2008","journal-title":"Transfus Med"},{"key":"key20160811141512375_ref1-bib61","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"key20160811141512375_ref1-bib62","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1056\/NEJM199902113400601","article-title":"A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group","volume":"340","author":"Hebert","year":"1999","journal-title":"N Eng J Med"},{"key":"key20160811141512375_ref1-bib63","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/HCO.0b013e328310fc95","article-title":"Increased mortality, morbidity, and cost associated with red blood cell transfusion after cardiac surgery","volume":"23","author":"Reeves","year":"2008","journal-title":"Curr Opin Cardiol"},{"key":"key20160811141512375_ref1-bib64","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1056\/NEJMoa070403","article-title":"Duration of red-cell storage and complications after cardiac surgery","volume":"358","author":"Koch","year":"2008","journal-title":"N Engl J Med"},{"key":"key20160811141512375_ref1-bib65","volume-title":"How Many [Cardiac Surgery] Operations are Carried Out Each Year?","author":"Blue Book Online","year":"2013"},{"key":"key20160811141512375_ref1-bib66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1211801","article-title":"Transfusion strategies for acute upper gastrointestinal bleeding","volume":"368","author":"Villanueva","year":"2013","journal-title":"N Engl J Med"},{"key":"key20160811141512375_ref1-bib67","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization","volume":"31","author":"Task Force on Myocardial Revascularisation of the European Society of Cardiology (ESC)","year":"2010","journal-title":"Eur Heart J"},{"key":"key20160811141512375_ref1-bib68","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ECS)","year":"2012","journal-title":"Eur Heart J"},{"key":"key20160811141512375_ref1-bib69","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1097\/00003246-199910000-00021","article-title":"Factors influencing the individual effects of blood transfusions on oxygen delivery and oxygen consumption","volume":"27","author":"Casutt","year":"1999","journal-title":"Crit Care Med"},{"key":"key20160811141512375_ref1-bib70","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/BF02482966","article-title":"The effects of cardiopulmonary bypass on postoperative oxygen metabolism","volume":"29","author":"Utoh","year":"1999","journal-title":"Surg Today"},{"key":"key20160811141512375_ref1-bib71","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1136\/bmj.325.7368.803","article-title":"Where does blood go? Prospective observational study of red cell transfusion in north England","volume":"325","author":"Wells","year":"2002","journal-title":"BMJ"},{"key":"key20160811141512375_ref1-bib72","volume-title":"Transfusion Requirements in Cardiac Surgery III (TRICS-III)","author":"Clinical Trials Registry"},{"key":"key20160811141512375_ref1-bib73","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.tmrv.2011.03.001","article-title":"The Age of Blood Evaluation (ABLE) randomized controlled trial: study design","volume":"25","author":"Lacroix","year":"2011","journal-title":"Transfus Med Rev"},{"key":"key20160811141512375_ref1-bib74","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1056\/NEJMoa1500704","article-title":"Age of transfused blood in critically ill adults","volume":"372","author":"Lacroix","year":"2015","journal-title":"N Engl J Med"},{"key":"key20160811141512375_ref1-bib75","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2004","edition":"47 edn."},{"issue":"58","key":"key20160811141512375_ref1-bib76","doi-asserted-by":"publisher","DOI":"10.3310\/hta17580","article-title":"Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project","volume":"17","author":"Lord","year":"2013","journal-title":"Health Technol Assess"},{"issue":"33","key":"key20160811141512375_ref1-bib77","doi-asserted-by":"publisher","DOI":"10.3310\/hta13330","article-title":"A multicentre randomised controlled trial of the use of continuous positive airway pressure and non-invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial","volume":"13","author":"Gray","year":"2009","journal-title":"Health Technol Assess"},{"key":"key20160811141512375_ref1-bib78","volume-title":"NICE Medical Technology Guidance 8: The VeriQ System for Assessing Graft Flow During Coronary Artery Bypass Graft Surgery","author":"NICE","year":"2011"},{"key":"key20160811141512375_ref1-bib79","volume-title":"Nutrition Support in Adults: Oral Nutrition Support, Enteral Tube Feeding and Parenteral Nutrition","author":"NICE","year":"2006"},{"key":"key20160811141512375_ref1-bib80","volume-title":"Drug Tariff. The Electronic Drug Tariff","author":"NHS Business Services Authority, NHS Prescription Services","year":"2014"},{"key":"key20160811141512375_ref1-bib81","volume-title":"NHS Direct National Health Services Trust Annual Report and Accounts 2012\/13","author":"NHS Direct National Health Services Trust","year":"2013"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta20600\/hta20600.xml","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2002524","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta20600\/hta20600.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2003441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:22:03Z","timestamp":1749061323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta20600\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":81,"journal-issue":{"issue":"60","published-online":{"date-parts":[[2016,8]]}},"alternative-id":["10.3310\/hta20600"],"URL":"https:\/\/doi.org\/10.3310\/hta20600","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"}]}}